Review



human gdf9 elisa kit  (Elabscience Biotechnology)


Bioz Verified Symbol Elabscience Biotechnology is a verified supplier
Bioz Manufacturer Symbol Elabscience Biotechnology manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 92
      Buy from Supplier

    Structured Review

    Elabscience Biotechnology human gdf9 elisa kit
    Distribution of <t>GDF9</t> in FF from the three PCOS phenotypes and control group. Data are presented as mean ± SD. d P < 0.01, compared with Control Group; a P < 0.01, compared with Control Group; b P < 0.05, compared with PCOS A; c P < 0.05, compared with PCOS B.
    Human Gdf9 Elisa Kit, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 92/100, based on 4 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+gdf9+elisa+kit/pmc11070807-107-13-17?v=Elabscience+Biotechnology
    Average 92 stars, based on 4 article reviews
    human gdf9 elisa kit - by Bioz Stars, 2026-08
    92/100 stars

    Images

    1) Product Images from "Comparing GDF9 in mature follicles and clinical outcomes across different PCOS phenotype"

    Article Title: Comparing GDF9 in mature follicles and clinical outcomes across different PCOS phenotype

    Journal: Heliyon

    doi: 10.1016/j.heliyon.2024.e29879

    Distribution of GDF9 in FF from the three PCOS phenotypes and control group. Data are presented as mean ± SD. d P < 0.01, compared with Control Group; a P < 0.01, compared with Control Group; b P < 0.05, compared with PCOS A; c P < 0.05, compared with PCOS B.
    Figure Legend Snippet: Distribution of GDF9 in FF from the three PCOS phenotypes and control group. Data are presented as mean ± SD. d P < 0.01, compared with Control Group; a P < 0.01, compared with Control Group; b P < 0.05, compared with PCOS A; c P < 0.05, compared with PCOS B.

    Techniques Used: Control

    Expression of GDF9 in the CCs. (a) Immunohistochemical staining of GDF9 expressed in the control group, phenotype A, phenotype B and phenotype D. (Original magnification: × 400, bars, 50 μm). (b) Mean density of GDF9 in CCs of the three PCOS phenotypes and control group, a P < 0.01, compared with Control Group; b P < 0.01, compared with PCOS D; c P < 0.01, compared with Control Group; d P < 0.01, compared with PCOS D.
    Figure Legend Snippet: Expression of GDF9 in the CCs. (a) Immunohistochemical staining of GDF9 expressed in the control group, phenotype A, phenotype B and phenotype D. (Original magnification: × 400, bars, 50 μm). (b) Mean density of GDF9 in CCs of the three PCOS phenotypes and control group, a P < 0.01, compared with Control Group; b P < 0.01, compared with PCOS D; c P < 0.01, compared with Control Group; d P < 0.01, compared with PCOS D.

    Techniques Used: Expressing, Immunohistochemical staining, Staining, Control

    Analysis of multiple factors affecting blastocyst formation and clinical pregnancy rate in the PCOS phenotypes.
    Figure Legend Snippet: Analysis of multiple factors affecting blastocyst formation and clinical pregnancy rate in the PCOS phenotypes.

    Techniques Used: Control



    Similar Products

    human gdf9 elisa kit  (Cusabio)
    93
    Cusabio human gdf9 elisa kit
    Human Gdf9 Elisa Kit, supplied by Cusabio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+gdf9+elisa+kit/pmc12273052-101-49-64?v=Cusabio
    Average 93 stars, based on 1 article reviews
    human gdf9 elisa kit - by Bioz Stars, 2026-08
    93/100 stars
    		  Buy from Supplier
    human gdf9 elisa kit  (Elabscience Biotechnology)
    92
    Elabscience Biotechnology human gdf9 elisa kit
    Distribution of <t>GDF9</t> in FF from the three PCOS phenotypes and control group. Data are presented as mean ± SD. d P < 0.01, compared with Control Group; a P < 0.01, compared with Control Group; b P < 0.05, compared with PCOS A; c P < 0.05, compared with PCOS B.
    Human Gdf9 Elisa Kit, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+gdf9+elisa+kit/pmc11070807-107-13-17?v=Elabscience+Biotechnology
    Average 92 stars, based on 1 article reviews
    human gdf9 elisa kit - by Bioz Stars, 2026-08
    92/100 stars
    		  Buy from Supplier

    Image Search Results


    Distribution of GDF9 in FF from the three PCOS phenotypes and control group. Data are presented as mean ± SD. d P < 0.01, compared with Control Group; a P < 0.01, compared with Control Group; b P < 0.05, compared with PCOS A; c P < 0.05, compared with PCOS B.

    Journal: Heliyon

    Article Title: Comparing GDF9 in mature follicles and clinical outcomes across different PCOS phenotype

    doi: 10.1016/j.heliyon.2024.e29879

    Figure Lengend Snippet: Distribution of GDF9 in FF from the three PCOS phenotypes and control group. Data are presented as mean ± SD. d P < 0.01, compared with Control Group; a P < 0.01, compared with Control Group; b P < 0.05, compared with PCOS A; c P < 0.05, compared with PCOS B.

    Article Snippet: The FF was diluted 1:5 in phosphase-buffered saline (PBS) and measured using a human GDF9 ELISA Kit (Elabscience, Wuhan, China) according to the manufacture's instructions.

    Techniques: Control

    Expression of GDF9 in the CCs. (a) Immunohistochemical staining of GDF9 expressed in the control group, phenotype A, phenotype B and phenotype D. (Original magnification: × 400, bars, 50 μm). (b) Mean density of GDF9 in CCs of the three PCOS phenotypes and control group, a P < 0.01, compared with Control Group; b P < 0.01, compared with PCOS D; c P < 0.01, compared with Control Group; d P < 0.01, compared with PCOS D.

    Journal: Heliyon

    Article Title: Comparing GDF9 in mature follicles and clinical outcomes across different PCOS phenotype

    doi: 10.1016/j.heliyon.2024.e29879

    Figure Lengend Snippet: Expression of GDF9 in the CCs. (a) Immunohistochemical staining of GDF9 expressed in the control group, phenotype A, phenotype B and phenotype D. (Original magnification: × 400, bars, 50 μm). (b) Mean density of GDF9 in CCs of the three PCOS phenotypes and control group, a P < 0.01, compared with Control Group; b P < 0.01, compared with PCOS D; c P < 0.01, compared with Control Group; d P < 0.01, compared with PCOS D.

    Article Snippet: The FF was diluted 1:5 in phosphase-buffered saline (PBS) and measured using a human GDF9 ELISA Kit (Elabscience, Wuhan, China) according to the manufacture's instructions.

    Techniques: Expressing, Immunohistochemical staining, Staining, Control

    Analysis of multiple factors affecting blastocyst formation and clinical pregnancy rate in the PCOS phenotypes.

    Journal: Heliyon

    Article Title: Comparing GDF9 in mature follicles and clinical outcomes across different PCOS phenotype

    doi: 10.1016/j.heliyon.2024.e29879

    Figure Lengend Snippet: Analysis of multiple factors affecting blastocyst formation and clinical pregnancy rate in the PCOS phenotypes.

    Article Snippet: The FF was diluted 1:5 in phosphase-buffered saline (PBS) and measured using a human GDF9 ELISA Kit (Elabscience, Wuhan, China) according to the manufacture's instructions.

    Techniques: Control